Non-viral gene delivery for p53

Current Opinion in Molecular Therapeutics

Volumn 2, Issue 2, 2000, Pages 168-175

  Pirollo, Kathleen F ^a   Xu, Liang ^a   Chang, Esther H ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Gene therapy; Ligand; Liposomes; Non viral vectors; p53

Indexed keywords

DNA; LIGAND; LIPOSOME; POLYMER; PROTEIN P53; VIRUS VECTOR;

CARCINOGENESIS; GENE MUTATION; GENE TARGETING; GENE THERAPY; HUMAN; METASTASIS; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; BIOLISTICS; DNA; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; LIPOSOMES; NEOPLASMS; POLYMERS;

EID: 0033993929     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Reviews: p53. In: Oncogene Reviews. Jenkins JR, Banks LM (Eds), Stockton Press, London (1999) 18:7617-7777.
2. Sidransky D, Hollstein M: Clinical implications of the p53 gene. Annu Rev Med (1996) 47:285-301.
3. Ruley HE: p53 and Response to Chemotherapy and Radiotherapy. In: Important Advances in Oncology. DeVita VT, Hellman S, Rosenberg SA (Eds), Lippincott-Raven Publishers, Philadelphia (1996):37-56.
4. Bristow RG, Benchimol S, Hill RP: The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy. Radiother Oncol (1996) 40:197-223.
5. Chiarugi V, Magnelli L, Gallo O: Cox-2, INOS and p53 as play-makers of tumor angiogenesis. Int J Mol Med (1998) 2:715-719.
6. Volpert OV, Dameron KM, Bouck N: Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene (1997) 14:1495-1502.
7. Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D: In vivo and In vitro gene transfer to mammalian somatic cells by particle bombardment Proc Natl Acad Sci USA (1990) 87:9568-9572.
8. Muramatsu T, Nakamura A, Park HM: In vivo electroporation: A powerful and convenient means of non-viral gene transfer to tissues of living animals. Int J Mol Med (1998) 1:55-62.
9. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J: In vivo electrically-mediated protein and gene transfer in murine melanoma. Nature Biotechnol (1998) 16:168-171.
10. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P, Mathiesen I, Cortese R, Ciliberto G, Laufer R, La Monica N, Fattori E: Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA (1999) 96:6417-6422.
11. Kouraklis G: Progress in cancer gene therapy. Acta Oncologica (1999) 38:675-683.
12. Sun WH, Burkholder JK, Sun J, Culp J, Turner J, Lu XG, Pugh TD, Ershler WB, Yang NS: In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc Natl Acad Sci USA (1995) 92:2889-2893.
13. Rakhmilevich AL, Turner J, Ford MJ, McCabe D, Sun WH, Sondel PM, Grota K, Yang NS: Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci USA (1996) 93:6291-6296.
14. Coll JL, Negoescu A, Louis N, Sachs L, Tenaud C, Girardot V, Demeneix B, Brambilla E, Brambilla C, Favrot M: Antitumor activity of bax and p53 naked gene transfer in lung cancer: In vitro and in vivo analysis. Hum Gene Ther (1938) 9:2063-2074.
15. Tüting T: The immunology of cutaneous DNA immunization. Curr Opin Mol Ther (1999) 1:216-225.
16. Wong FM, Reimer DL, Bally MB: Cationic lipid binding to DNA: Characterization of complex formation. Biochemistry (1996) 35:5756-5763.
17. Clark PR, Hersh EM: Cationic lipid-mediated gene transfer: Current concepts. Curr Opin Mol Ther (1999) 1:158-176.
18. Recombinant DNA Advisory Committee (RAC) Committee Report: Human Gene Therapy Protocols (1998).
19. Zou Y, Zong G, Ling YH, Hao MM, Lozano G, Hong WK, Perez-Soler R: Effective treatment of early endobronchial cancer with regional administration of liposome-p53. J Natl Cancer Inst (1998) 90:1130-1137.
20. 33 P]DNA following intravenous administration of DNA/cationic lipld complexes in mice: Use of a novel radionuclide approach. J Pharm Sci (1996) 85:612-618.
21. Liu Y, Mounkes LC, Liggitt HD, Brown CS, Solodin I, Heath TD, Debs RJ: Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotechnol (1997) 15:167-173.
22. Lesoon-Wood LA, Kim WH, Kleinman HK, Weintraub BD, Mixson AJ: Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther (1995) 6:395-405.
23. Chen QR, Mixson AJ: Systemic gene therapy with p53 inhibits breast cancer: Recent advances and therapeutic implications. Frontiers Bioscience (1998) 3:D997-D1004.
24. Xu M, Kumar D, Srinivas S, Detolla LJ, Yu SF, Stass SA, Mixson AJ: Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity. Hum Gene Ther (1997) 8:177-185.
25. Xu M, Kumar D, Stass SA, Mixson AJ: Gene therapy with p53 and a fragment of thrombospondin I inhibits human breast cancer in vivo. Mol Genet Metab (1998) 63:103-109.
26. Liu Y, Thor A, Shtivelman E, Cao Y, Tu G, Heath TD, Debs RJ: Systemic gene delivery expands the repertoire of effective antiangiogenic agents. J Biol Chem (1999) 274:13338-13344.
27. Simões S, Pires P, Düzgünes N, Pedroso de Lima M: Cationic liposomes as gene transfer vectors: Barriers to successful application in gene therapy. Curr Opin Mol Ther (1999) 1:147-157.
28. Cristiano RJ, Curiel DT: Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther (1996) 3:49-57.
29. Cheng PW: Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther (1996) 7:275-282.
30. Antony AC: Folate receptors. Annu Rev Nutr (1996) 16:501-521.
31. Lee RJ, Low PS: Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem (1994) 269:3198-3204.
32. Chang EH, Xu L, Pirollo KF: Targeted p53 gene therapy-mediated radiosensitization and chemosensltization. In: Signaling Networks and Cell Cycle Control: The Molecular Basis of Cancer and Other Diseases. Gutkind JS, Totowa NJ (Eds), Humana Press Inc (1999):521-538.
33. Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA: Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Mod (1996) 37:1003-1008.
34. Xu L, Pirollo KF, Rait A, Murray AL, Chang EH: Systematic p53 gene therapy in combination with radiation results in human tumor regression. Tumor Targeting (1999) 4:92-104.
35. Baselga J, Mendelsohn J: Receptor blockade with monoclonal antibodies as anticancer therapy. Pharmacol Ther (1994) 64:127-154.
36. Hoogenboom HR, Raus JC, Volckaert G: Cloning and expression of a chimeric antibody directed against the human transferrin receptor. J Immunol (1990) 144:3211-3217.
37. Xu L, Pirollo KF, Chang EH: Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck radiation in vitro. Hum Gene Ther (1997) 8:467-475.
38. Xu L, Pirollo KF, Tang WH, Raft A, Chang EH: Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther (1999) 10:2941-2952.
39. Kao GY, Change LJ, Allen TM: Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells. Cancer Gene Ther (1996) 3:250-256.
40. Pak CG, Erukulla RK, Ahl PL, Janoff AS, Meers P: Elastase activated liposomal delivery to nucleated cells. Biochim Biophys Acta (1999) 1419:111-126.
41. Radler JO, Koltover I, Salditt T, Safinya CR: Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science (1997) 275:810-814.
42. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN: Improved DNA: Liposome complexes for increased systemic delivery and gene expression. Nature Biotechnol (1997) 15:647-652.
43. Reddy JA, Low PS: Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release (2000) 64:27-37.
44. Wagner E: Ligand-polycation conjugates for receptor-targeted gene transfer. In: Non-viral Vectors for Gene Therapy. Huang L, Hung MC, Wagner E (Eds), Academic Press, San Diego, CA (1999):208-227.
45. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethytenimine. Proc Natl Acad Sci USA (1995) 92:7297-7301.
46. Kichler A: Polyethylenimines: A family of potent polymers for nucleic acid delivery. In: Non-viral Vectors for Gene Therapy. Huang L, Hung MC, Wagner E (Eds), Academic Press, San Diego, CA (1999):92-206.
47. Godbey WT, Wu KK, Mikos AQ: Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 60:149-160.
48. Erbacher P, Remy JS, Behr JP: Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther (1999) 6:138-145.
49. Diebold SS, Kursa M, Wagner E, Cotten M, Zenke M: Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem (1999) 274:19087-19094.
50. Bettinger T, Remy JS, Erbacher P: Size reduction of galactosylated PEI/DNA complexes improves lectinmediated gene transfer into hepatocytes. Bioconjug Chem (1999) 10:558-561.
51. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E: PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation In blood and potential for systemic gene delivery. Gene Ther (1999) 6:595-605.
52. Kircheis R, Kichler A, Wallner G, Kursa M, Ogris M, Felzmann T, Buchberger M, Wagner E: Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther (1997) 4:409-418.
53. Yoo H, Sazani P, Juliano RL: PAMAM dendrimers as delivery agents for antisense olligonucleotides. Pharm Res (1999) 16:1799-1804.
54. Xu M, Chen QR, Kumar D, Stass SA, Mixson AJ: In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes. Mol Genet Metab (1998) 64:193-197.
55. Huang L, Viroonchatapan E: Introduction. In: Non-viral Vectors for Gene Therapy. Huang L, Hung MC, Wagner E (Eds), Academic Press, San Diego, CA (1999):3-22.
56. Gonzalez H, Hwang SJ, Davis ME: New class of polymers for the delivery of macromolecular therapeutics. Bioconjug Chem (1999) 10:1068-1074.
57. Papahadjopoulos D: Stealth liposomes: From steric stabilization to targeting. Stealth Liposomes (1995):1-6.
58. Hong K, Zheng W, Baker A, Papahadjopoulos D: Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient In vivo gene delivery. FEBS Lett (1997) 400:233-237.
59. Wheeler JJ, Palmer L, Ossanlou M, MacLachlan I, Graham RW, Zhang YP, Hope MJ, Scherrer P, Cullis PR: Stabilized plasmid-lipid particles: Construction and characterization. Gene Ther (1999) 6:271-281.
60. Mok KW, Lam AM, Cullis PR: Stabilized plasmid-lipid particles: Factors influencing plasmid entrapment and transfection properties. Biochim Biophys Acta (1999) 1419:137-150.
61. Kwoh DY, Coffin CC, Lollo CP, Jovenal J, Banaszczyk MG, Mullen P, Phillips A, Amini A, Fabrycki J, Bartholomew RM, Brostoff SW, Carlo DJ: Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim Biophys Acta (1999) 1444:171-190.
62. Kircheis R, Schuller S, Brunner S, Ogris M, Heider KH, Zauner W, Wagner E: Polycation-based DNA complexes for tumortargeted gene delivery in vivo. J Gene Med (1999) 1:111-120.
63. Xu L, Chang EH: Tumor-targeted gene therapy by ligand-PEG 'post-coated' cationic liposomes. Proceedings of the 1999 AACR NCI EORTC International Conference, Clinical Cancer Research Supplement (1999) 5:502.